Eli Lilly's $3.25 billion acquisition of Kelonia Therapeutics caps startup's tortuous ride statnews.comLilly to buy Boston biotech Kelonia for $3.25 billion in latest Mass. investment The Boston GlobeEli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBCWhy Legend Biotech Stock Crushed the Market on Monday The Motley Fool
London-based healthcare and life science Apposite Capital has launched a new growth-focused health fund, anchored by a £100m commitments from the British Business Bank.
The post Apposite Capital seals £100m British Business Bank anchor commitment for UK-focused healthtech fund appeared first on AltAssets Private Equity News.
